Key Takeaways
- Blood thinners are not an absolute contraindication for dental implants.
- Older vitamin K antagonists (Marcumar, Sintrom) require close INR monitoring — discontinuation is usually unnecessary and can be more dangerous.
- Newer direct oral anticoagulants (Eliquis, Xarelto, Pradaxa) have shorter half-lives and are often easier to manage perioperatively.
- Antiplatelet agents (aspirin, clopidogrel) moderately increase bleeding risk — discontinuation is generally not indicated.
- Close coordination between implantologist and cardiologist/internist before the procedure is essential.
Blood thinners and dental implants: Is it possible?
Millions of people take blood thinners daily — after a heart attack, for atrial fibrillation, following a thrombosis, or with a heart valve prosthesis. When these patients need a dental implant, the immediate question arises: do I have to stop the medication? Is the procedure even safe?
The good news: in most cases, a dental implant is possible even under anticoagulation — but planning must be careful and individualised. This guide explains the main drug classes, their risks, and what you need to know before the procedure.
Main drug classes at a glance
| Class | Agents (brand names) | Indication | Bleeding risk |
|---|---|---|---|
| Vitamin K antagonists (VKA) | Phenprocoumon (Marcumar), Acenocoumarol (Sintrom) | Atrial fibrillation, heart valve, thrombosis | Moderate–high (INR-dependent) |
| Direct oral anticoagulants (DOAC) | Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Edoxaban (Lixiana) | Atrial fibrillation, thrombosis prophylaxis | Moderate (shorter half-life) |
| Antiplatelet agents | Aspirin (ASS 100), Clopidogrel (Plavix), Ticagrelor (Brilique) | CAD, stent, MI prophylaxis | Low–moderate |
| Low molecular weight heparin | Enoxaparin (Clexane), Dalteparin (Fragmin) | Thrombosis prophylaxis, bridging | Low (short half-life) |
Marcumar and Sintrom: The INR value decides
Vitamin K antagonists such as phenprocoumon (Marcumar) are widely used in Austria. They inhibit coagulation via vitamin K metabolism and are monitored by the INR (International Normalized Ratio). An INR of 2.0–3.0 is therapeutic for most indications.
Important: Do NOT stop Marcumar on your own
Stopping Marcumar without medical supervision significantly increases the risk of stroke or thromboembolism — in most cases this risk outweighs the bleeding risk from the implant procedure. The decision is always made by your cardiologist or internist, not the dentist.
Eliquis, Xarelto, Pradaxa: The newer anticoagulants
Direct oral anticoagulants (DOACs) have replaced Marcumar in many indications. Their advantage: shorter half-life (6–12 hours), no INR monitoring required, fewer food interactions. This considerably simplifies perioperative management.
Common approach for DOACs
For most implant procedures (single implant, uncomplicated), the morning dose on the day of surgery is omitted and the evening dose is resumed after confirmed haemostasis. This decision is made by the cardiologist — not the implantologist alone.
| Agent | Brand name | Half-life | Pause before procedure |
|---|---|---|---|
| Apixaban | Eliquis | 8–15 hrs | 12–24 hrs (last dose) |
| Rivaroxaban | Xarelto | 5–13 hrs | 12–24 hrs (last dose) |
| Dabigatran | Pradaxa | 12–17 hrs | 24–48 hrs (renal-dependent) |
| Edoxaban | Lixiana | 10–14 hrs | 12–24 hrs (last dose) |
Aspirin and clopidogrel: Antiplatelet agents
Aspirin (ASS 100 mg) and clopidogrel (Plavix) inhibit platelet aggregation and are used after myocardial infarction, stent implantation, or in coronary artery disease. Their bleeding risk in dental procedures is significantly lower than anticoagulants.
Guideline recommendation
Current guidelines recommend not stopping aspirin or clopidogrel before dental procedures. The thromboembolic risk from discontinuation outweighs the bleeding risk. Local haemostatic measures are sufficient.
Special case: Combination of multiple medications
Some patients take both an anticoagulant and an antiplatelet agent simultaneously — for example Eliquis + aspirin after a heart attack with atrial fibrillation. In these cases, bleeding risk increases considerably and planning requires particularly close interdisciplinary coordination.
When an implant should be postponed
- Dual antiplatelet therapy within the first 6 months after stent implantation
- INR above 3.5 (unstable anticoagulation)
- Active bleeding tendency or thrombocytopenia
- Planned bridging therapy with heparin (increased risk)
Conclusion: Blood thinners are not an obstacle — but planning is everything
The vast majority of patients on anticoagulation can safely receive a dental implant. What matters is not the medication alone, but careful interdisciplinary planning between implantologist, cardiologist, and GP. At IIDZ Vienna, we conduct an individual risk analysis before every procedure and coordinate perioperative management closely with your treating physician.
More from our risk factors series: Read our guides on Dental Implants for Seniors and Dental Implants with Osteoporosis.
Digital Planning in Anticoagulated Patients
For patients on blood thinner therapy, a minimally invasive surgical technique is especially important — and this is exactly where digital planning demonstrates its strengths. DVT-guided computer-assisted implant planning with a guided surgery template allows the implant to be placed precisely and without large incisions. This significantly reduces the bleeding surface and makes the procedure safer even for patients where discontinuing anticoagulants is not possible.
Institut für Implantologie und digitale Zahnmedizin Wien
Fachärztliches Team IIDZ Wien
Weitere Artikel
Thematisch verwandt
Hinweis: Diese Inhalte dienen ausschließlich der allgemeinen Information und ersetzen keine individuelle zahnärztliche Beratung. Das Institut für Implantologie und digitale Zahnmedizin Wien ist eine gemeinnützige, unabhängige Wissenschaftsplattform — kein Behandlungsbetrieb. Alle Angaben entsprechen dem aktuellen Stand der wissenschaftlichen Literatur; individuelle Behandlungsentscheidungen müssen stets mit einem approbierten Zahnarzt oder Facharzt getroffen werden.